Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Infection ; 40(5): 527-35, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22711599

ABSTRACT

BACKGROUND: The characteristics of patients with infective endocarditis (IE) vary significantly by region of the world. The aim of this study was to evaluate the contemporary epidemiology, characteristics, and outcome of IE in a large, nationwide cohort of Italian patients. METHODS: We conducted a prospective, observational study at 24 medical centers in Italy, including all the consecutive patients with a definite or possible diagnosis of IE (modified Duke criteria) admitted from January 2004 through December 2009. A number of clinical variables were collected through an electronic case report form and analyzed to comprehensively delineate the features of IE. We report the data on patients with definite IE. RESULTS: A total of 1,082 patients with definite IE were included. Of these, 753 (69.6%) patients had infection on a native valve, 277 (25.6%) on a prosthetic valve, and 52 (4.8%) on an implantable electronic device. Overall, community-acquired (69.2%) was more common than nosocomial (6.2%) or non-nosocomial (24.6%) health care-associated IE. Staphylococcus aureus was the most common pathogen (22.0%). In-hospital mortality was 15.1%. From the multivariate analysis, congestive heart failure (CHF), stroke, prosthetic valve infection, S. aureus, and health care-associated acquisition were independently associated with increased in-hospital mortality, while surgery was associated with decreased mortality. CONCLUSIONS: The current mortality of IE remains high, and is mainly due to its complications, such as CHF and stroke.


Subject(s)
Endocarditis, Bacterial/epidemiology , Adult , Aged , Aged, 80 and over , Analysis of Variance , Female , Humans , Italy/epidemiology , Male , Middle Aged , Odds Ratio , Prospective Studies , Risk Factors , Treatment Outcome , Young Adult
2.
Infection ; 40(5): 557-62, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22544764

ABSTRACT

PURPOSE: West Nile virus (WNV) transmission through organ transplantation occurs rarely and screening of organ donors for WNV infection remains controversial. This report describes the case of WNV encephalitis in a kidney recipient and the case of asymptomatic WNV infection in the organ donor, both observed at Treviso Hospital, northeastern Italy. After briefly reviewing the literature, we discuss the implications for WNV screening. METHODS: We reviewed medical, laboratory and epidemiological records at our hospital, and the literature concerning cases of organ-transmitted WNV infections and WNV screening of organ donors in Italy and worldwide. RESULTS: The kidney recipient was the first confirmed case of WNV infection notified in northeastern Italy in 2011, and the first case of WNV infection in a cluster of four transplant recipients who acquired the infection from a common organ donor. The organ donor, whose WNV infection was only retrospectively diagnosed by IgM detection, represents the index case of a WNV outbreak in the Treviso Province. Screening of her blood prior to organ recovery did not show detectable levels of WNV nucleic acid with the use of quantitative real-time polymerase chain reaction. CONCLUSIONS: This report emphasizes that transplant-acquired WNV neuroinvasive disease can be particularly severe. We suggest that pre-procurement screening of organ donors by testing blood with both WNV IgM capture ELISA and a sensitive nucleic acid testing should be adopted during the transmission season in the present Italian epidemiological setting.


Subject(s)
Tissue Donors , Transplantation , Transplants/adverse effects , West Nile Fever/transmission , West Nile virus/isolation & purification , Adult , Antibodies, Viral/blood , Coma/virology , Female , Humans , Italy , Male , RNA, Viral/blood , Transplants/virology , West Nile Fever/diagnosis , West Nile Fever/virology
3.
Infez Med ; 17(1): 41-5, 2009 Mar.
Article in Italian | MEDLINE | ID: mdl-19359826

ABSTRACT

Cryptococcus neoformans is a ubiquitous fungal pathogen which causes human disease ranging from asymptomatic colonization of the lungs, to severe pneumonia, mediastinitis, meningitis or generalized infection. Although cryptococcal infection shows notably opportunistic features, it is sometimes also found among apparently immunocompetent individuals, with an extremely adverse outcome in the case of SNC involvement. Therefore, when faced with a presumed healthy person with anamnestic, clinical, CSF and instrumental findings consistent with chronic meningitis/meningoencephalitis, we must also consider cryptococcosis as a possible cause of disease. This may be rapidly achieved by resorting to quite a simple serological test, namely cryptococcal antigen detection. We describe two cases of cryptococcal meningoencephalitis occurring among apparently immunocompetent subjects (both HIV-negative, not under corticosteroid or immunosuppressive regimen, nor undergoing chemotherapy or radiotherapy. Laboratory diagnostics revealed the existence of reasonable immunological deficit for both subjects. Unfortunately, we were unable to establish whether the alterations in question were preexisting or concomitant with fungal infection. Our patients' course was somewhat problematic, according to findings observed in broader-based studies: this could mostly be explained by the considerable diagnostic delay which often marks cryptococcal infections of immunocompetent individuals. Nevertheless, neither of these two cases were complicated by intracranial pressure increase, leading us to speculate whether this disease may occur less frequently under conditions of substantial immunological integrity.


Subject(s)
Cryptococcus neoformans/isolation & purification , Meningitis, Cryptococcal/microbiology , Meningoencephalitis/microbiology , Aged , Antigens, Fungal/blood , Brain Damage, Chronic/etiology , Cryptococcus neoformans/immunology , Deafness/etiology , Humans , Immunocompetence , Male , Meningitis, Cryptococcal/complications , Meningitis, Cryptococcal/immunology , Meningoencephalitis/complications , Meningoencephalitis/immunology , Middle Aged , Paraparesis/etiology
4.
Infez Med ; 16(3): 154-7, 2008 Sep.
Article in Italian | MEDLINE | ID: mdl-18843213

ABSTRACT

Brucellosis is one of the most common zoonoses in the world. Its distribution has changed in recent years due to socioeconomic factors and international travel. In Italy its trend has followed the international pattern, albeit with major differences between the north and south of the country. In northern Italy brucellosis is import-related and rarely laboratory acquired. We describe an outbreak of five cases of brucella infection occurred in Treviso province during August 2005. All the patients had a positive Wright test and two of them had a positive blood culture for Brucella abortus. The source of infection was cheese from an area of Italy where brucellosis is endemic. All the people who consumed the cheese had clinical and laboratory signs of brucellosis. All of them received six weeks of rifampin and doxycycline treatment; none developed any complication or relapse during the two follow-up years. In conclusion, brucellosis should be considered as a differential diagnosis of fever of unknown origin even in countries where it is not endemic; it is necessary not only to rule out travels to endemic regions through clinical history, but also the consumption of infected foods imported from such areas.


Subject(s)
Brucella abortus/isolation & purification , Brucellosis/epidemiology , Cheese/adverse effects , Cheese/microbiology , Disease Outbreaks , Endemic Diseases , Food Contamination , Food Microbiology , Sheep Diseases/epidemiology , Adult , Aged , Animals , Bacteremia/etiology , Bacteremia/microbiology , Brucellosis/etiology , Brucellosis/microbiology , Brucellosis/transmission , Brucellosis/veterinary , Endemic Diseases/veterinary , Female , Humans , Incidence , Italy/epidemiology , Male , Middle Aged , Sheep/microbiology , Sheep Diseases/microbiology , Sheep Diseases/transmission
5.
Infection ; 30(3): 161-3, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12120943

ABSTRACT

BACKGROUND: We report our experience with quinupristin/ dalfopristin in combination with a glycopeptide in the treatment of severe staphylococcal infections failing previous glycopeptide regimens. PATIENTS AND METHODS: Five patients, affected by persistent bacteremia (n = 2), post-cardiothoracic surgery infection (n = 2) and post-traumatic bone infection (n = 1) due to methicillin-resistant Staphylococcus aureus (MRSA, n = 4) methicillin-resistant coagulase-negative Staphylococcus (MRCNS, n = 1) and unsuccessfully treated with antibiotics including a glycopeptide, were treated with a quinupristin/ dalfopristin and glycopeptide combination. RESULTS: Three patients were clinically cured; one patient with MRSA thoracic aorta prosthetic infection relapsed after 3 months; one patient was lost to follow-up. CONCLUSION: Quinupristin/dalfopristin, in combination with a glycopeptide, is an effective treatment option for severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Methicillin Resistance , Staphylococcal Infections/drug therapy , Virginiamycin/analogs & derivatives , Virginiamycin/administration & dosage , Adult , Aged , Anti-Bacterial Agents/pharmacology , Colony Count, Microbial , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Male , Microbial Sensitivity Tests , Sampling Studies , Sensitivity and Specificity , Severity of Illness Index , Staphylococcal Infections/diagnosis , Teicoplanin/pharmacology , Treatment Outcome , Vancomycin/pharmacology , Virginiamycin/pharmacology
6.
Clin Infect Dis ; 33(9): e109-11, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11577376

ABSTRACT

We have assessed levofloxacin penetration in cerebrospinal fluid (CSF) and the liquor-to-plasma ratio (C(L)/C(P)) at 2 hours after dosing in 5 patients with spontaneous acute bacterial meningitis. CSF levofloxacin concentration at 2 hours after dosing was 1.99+/-0.67 microg/mL, and the C(L)/C(P) at 2 hours after dosing was 0.34+/-0.09.


Subject(s)
Anti-Infective Agents/cerebrospinal fluid , Levofloxacin , Meningitis, Escherichia coli/cerebrospinal fluid , Meningitis, Meningococcal/cerebrospinal fluid , Meningitis, Pneumococcal/cerebrospinal fluid , Ofloxacin/cerebrospinal fluid , Acute Disease , Adult , Aged , Anti-Infective Agents/pharmacokinetics , Anti-Infective Agents/therapeutic use , Female , Humans , Male , Meningitis, Escherichia coli/drug therapy , Meningitis, Meningococcal/drug therapy , Meningitis, Pneumococcal/drug therapy , Middle Aged , Ofloxacin/pharmacokinetics , Ofloxacin/therapeutic use
9.
Infection ; 27(3): 228-30, 1999.
Article in English | MEDLINE | ID: mdl-10378139

ABSTRACT

Cytomegalovirus (CMV)-associated transverse myelitis is rare in immunocompetent patients. The case of a 54-year-old man is reported here who developed acute transverse myelitis with cerebrospinal fluid (CSF) alterations, suggesting a central nervous system infection. CMV-IgM positivity in serum and CMV isolated from blood, positive CMV PCR and positivity for pp65 antigen in blood, without viral antigens in the CSF and a positive response to therapy with ganciclovir (followed by progressive improvement) supported the diagnosis.


Subject(s)
Cytomegalovirus Infections/virology , Cytomegalovirus , Myelitis, Transverse/virology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Antigens, Viral/immunology , Cytomegalovirus/immunology , Cytomegalovirus Infections/blood , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/immunology , Humans , Immunocompromised Host , Male , Middle Aged , Myelitis, Transverse/blood , Myelitis, Transverse/drug therapy , Myelitis, Transverse/immunology , Phosphoproteins/immunology , Viral Matrix Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...